Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 561

1.

Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802.

Holtan SG, DeFor TE, Panoskaltsis-Mortari A, Khera N, Levine JE, Flowers MED, Lee SJ, Inamoto Y, Chen GL, Mayer S, Arora M, Palmer J, Cutler CS, Arai S, Lazaryan A, Newell LF, Jagasia MH, Pusic I, Wood WA, Renteria AS, Yanik G, Hogan WJ, Hexner E, Ayuk F, Holler E, Bunworasate U, Efebera YA, Ferrara JLM, Pidala J, Howard A, Wu J, Bolaños-Meade J, Ho V, Alousi A, Blazar BR, Weisdorf DJ, MacMillan ML.

Blood Adv. 2018 Aug 14;2(15):1882-1888. doi: 10.1182/bloodadvances.2018017343.

2.

Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation.

Roeker LE, Kim HT, Glotzbecker B, Nageshwar P, Nikiforow S, Koreth J, Armand P, Cutler C, Alyea EP, Antin JH, Richardson PG, Soiffer RJ, Ho VT.

Biol Blood Marrow Transplant. 2018 Aug 3. pii: S1083-8791(18)30428-2. doi: 10.1016/j.bbmt.2018.07.039. [Epub ahead of print]

PMID:
30081073
3.

Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated.

Nikiforow S, Wang T, Hemmer M, Spellman S, Akpek G, Antin JH, Choi SW, Inamoto Y, Khoury HJ, MacMillan M, Marks DI, Meehan K, Nakasone H, Nishihori T, Olsson R, Paczesny S, Przepiorka D, Reddy V, Reshef R, Schoemans H, Waller N, Weisdorf D, Wirk B, Horowitz M, Alousi A, Couriel D, Pidala J, Arora M, Cutler C.

Haematologica. 2018 Aug 3. pii: haematol.2017.182550. doi: 10.3324/haematol.2017.182550. [Epub ahead of print]

4.

Lip repositioning with or without myotomy: A randomized clinical trial.

Tawfik OK, Naiem SN, Tawfik LK, Yussif N, Meghil MM, Cutler CW, Darhous M, El-Nahass HE.

J Periodontol. 2018 Jul 14. doi: 10.1002/JPER.17-0598. [Epub ahead of print]

PMID:
30006937
5.

From manual periodontal probing to digital 3-D imaging to endoscopic capillaroscopy: Recent advances in periodontal disease diagnosis.

Elashiry M, Meghil MM, Arce RM, Cutler CW.

J Periodontal Res. 2018 Jul 4. doi: 10.1111/jre.12585. [Epub ahead of print] Review.

PMID:
29974960
6.

Open-source 3D printed sensors for hand strength assessment: Validation of low-cost load cell and fabric sensor-based systems.

Cutler CR, Hamilton AL, Hough E, Baines CM, Clark RA.

Aust Occup Ther J. 2018 Jul 3. doi: 10.1111/1440-1630.12494. [Epub ahead of print]

PMID:
29971790
7.

Cytomegalovirus Infection Among Cord Blood Allogeneic Transplantation Recipients: Low Incidence of Cytomegalovirus Events without High-Dose Valacyclovir Prophylaxis.

Knoll BM, Peixoto D, Koo S, Hammond SP, Ho VT, Antin JH, Soiffer RJ, Cutler C, Marty FM.

Biol Blood Marrow Transplant. 2018 Jun 30. pii: S1083-8791(18)30368-9. doi: 10.1016/j.bbmt.2018.06.029. [Epub ahead of print] No abstract available.

PMID:
29969749
8.

A phase II/III randomized, multicenter trial of Prednisone /Sirolimus vs Prednisone/Sirolimus/Calcineurin Inhibitor for treatment of chronic graft-versus-host disease: BMT CTN 0801.

Carpenter PA, Logan BR, Lee SJ, Weisdorf DJ, Johnston L, Costa LJ, Kitko CL, Bolaños-Meade J, Sarantopoulos S, Alousi AM, Abhyankar S, Waller EK, Mendizabal A, Zhu J, O'Brien KA, Lazaryan A, Wu J, Nemecek ER, Pavletic SZ, Cutler CS, Horowitz MM, Arora M; Blood and Marrow Clinical Trials Network.

Haematologica. 2018 Jun 28. pii: haematol.2018.195123. doi: 10.3324/haematol.2018.195123. [Epub ahead of print]

9.

Antibacterial efficacy of an endodontic sonic-powered irrigation system: An in vitro study.

Zeng C, Willison J, Meghil MM, Bergeron BE, Cutler CW, Tay FR, Niu L, Ma J.

J Dent. 2018 Aug;75:105-112. doi: 10.1016/j.jdent.2018.06.003. Epub 2018 Jun 13.

PMID:
29908290
10.

Integrated genomic characterization of oral carcinomas in post-hematopoietic stem cell transplantation survivors.

Hanna GJ, Kofman ER, Shazib MA, Woo SB, Reardon B, Treister NS, Haddad RI, Cutler CS, Antin JH, Van Allen EM, Uppaluri R, Soiffer RJ.

Oral Oncol. 2018 Jun;81:1-9. doi: 10.1016/j.oraloncology.2018.04.007. Epub 2018 Apr 10.

PMID:
29884406
11.

Optimizing resin-dentin bond stability using a bioactive adhesive with concomitant antibacterial properties and anti-proteolytic activities.

Gou YP, Meghil MM, Pucci CR, Breschi L, Pashley DH, Cutler CW, Niu LN, Li JY, Tay FR.

Acta Biomater. 2018 Jun 6. pii: S1742-7061(18)30344-1. doi: 10.1016/j.actbio.2018.06.008. [Epub ahead of print]

PMID:
29883811
12.

Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation.

Postalcioglu M, Kim HT, Obut F, Yilmam OA, Yang J, Byun BC, Kupiec-Weglinski S, Soiffer R, Ritz J, Antin JH, Alyea E, Koreth J, Cutler C, Armand P, Paik JM, Leaf DE, Ho VT, Abdi R.

Biol Blood Marrow Transplant. 2018 May 11. pii: S1083-8791(18)30262-3. doi: 10.1016/j.bbmt.2018.05.010. [Epub ahead of print]

PMID:
29758394
13.

Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants.

Kumar AJ, Kim S, Hemmer MT, Arora M, Spellman SR, Pidala JA, Couriel DR, Alousi AM, Aljurf MD, Cahn JY, Cairo MS, Cutler CS, Farhan S, Gergis U, Hale GA, Hashmi SK, Inamoto Y, Kamble RT, Kharfan-Dabaja MA, MacMillan ML, Marks DI, Nakasone H, Norkin M, Qayed M, Ringden O, Schouten HC, Schultz KR, Solh MM, Teshima T, Urbano-Ispizua A, Verdonck LF, Gale RP, Hamilton BK, Majhail NS, Loren AW.

Blood Adv. 2018 May 8;2(9):1022-1031. doi: 10.1182/bloodadvances.2017013052. Erratum in: Blood Adv. 2018 Jun 12;2(11):1294.

14.

Letter to the Editor: International Consensus Radiochemistry Nomenclature Guidelines.

Coenen HH, Gee AD, Adam M, Antoni G, Cutler CS, Fujibayashi Y, Jeong JM, Mach RH, Mindt TL, Pike VW, Windhorst AD.

Curr Radiopharm. 2018;11(1):73-75. doi: 10.2174/187447101101180404111248. No abstract available.

PMID:
29624156
15.

Antimicrobial efficacy of an apical negative pressure root canal irrigation system against intracanal microorganisms.

Zeng C, Meghil MM, Miller M, Gou Y, Cutler CW, Bergeron BE, Niu L, Ma J, Tay FR.

J Dent. 2018 May;72:71-75. doi: 10.1016/j.jdent.2018.03.008. Epub 2018 Mar 20.

PMID:
29571954
16.

A trithiol bifunctional chelate for 72,77As: A matched pair theranostic complex with high in vivo stability.

Feng Y, DeGraffenreid AJ, Phipps MD, Rold TL, Okoye NC, Gallazzi FA, Barnes CL, Cutler CS, Ketring AR, Hoffman TJ, Jurisson SS.

Nucl Med Biol. 2018 Jun;61:1-10. doi: 10.1016/j.nucmedbio.2018.03.001. Epub 2018 Mar 10.

PMID:
29571038
17.

A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis.

Gooptu M, Kim HT, Ho VT, Alyea EP, Koreth J, Armand P, Ritz J, Nikiforow S, Glotzbecker BE, Nageshwar P, Soiffer RJ, Antin JH, Cutler CS.

Biol Blood Marrow Transplant. 2018 Mar 16. pii: S1083-8791(18)30124-1. doi: 10.1016/j.bbmt.2018.03.011. [Epub ahead of print]

PMID:
29555313
18.

International Consensus Radiochemistry Nomenclature Guidelines.

Coenen HH, Gee AD, Adam M, Antoni G, Cutler CS, Fujibayashi Y, Jeong JM, Mach RH, Mindt TL, Pike VW, Windhorst AD.

Nuklearmedizin. 2018 Feb;57(1):40-41. doi: 10.1055/s-0038-1636563. Epub 2018 Feb 21. No abstract available.

PMID:
29536500
19.

Open letter to journal editors on: international consensus radiochemistry nomenclature guidelines.

Coenen HH, Gee AD, Adam M, Antoni G, Cutler CS, Fujibayashi Y, Jeong JM, Mach RH, Mindt TL, Pike VW, Windhorst AD.

Am J Nucl Med Mol Imaging. 2018 Feb 5;8(1):70-72. eCollection 2018. No abstract available.

20.

Economic and Practical Considerations in the Treatment of Oral Mucosal Chronic Graft-Versus-Host Disease.

Elad S, Zinchuk K, Li S, Cutler C, Liesveld J, Treister NS.

Biol Blood Marrow Transplant. 2018 Mar 2. pii: S1083-8791(18)30108-3. doi: 10.1016/j.bbmt.2018.02.022. [Epub ahead of print]

PMID:
29501781
21.

Open letter to journal editors on: International Consensus Radiochemistry Nomenclature Guidelines.

Coenen HH, Gee AD, Adam M, Antoni G, Cutler CS, Fujibayashi Y, Jeong JM, Mach RH, Mindt TL, Pike VW, Windhorst AD.

Nucl Med Commun. 2018 Mar;39(3):193-195. doi: 10.1097/MNM.0000000000000799. No abstract available.

PMID:
29438216
22.

α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease.

Magenau JM, Goldstein SC, Peltier D, Soiffer RJ, Braun T, Pawarode A, Riwes MM, Kennel M, Antin JH, Cutler CS, Ho VT, Alyea EP 3rd, Parkin BL, Yanik GA, Choi SW, Lewis EC, Dinarello CA, Koreth J, Reddy P.

Blood. 2018 Mar 22;131(12):1372-1379. doi: 10.1182/blood-2017-11-815746. Epub 2018 Feb 2.

PMID:
29437593
23.

Open letter to journal editors on: International Consensus Radiochemistry Nomenclature Guidelines.

Coenen HH, Gee AD, Adam M, Antoni G, Cutler CS, Fujibayashi Y, Jeong JM, Mach RH, Mindt TL, Pike VW, Windhorst AD.

Ann Nucl Med. 2018 Apr;32(3):236-238. doi: 10.1007/s12149-018-1238-z. Epub 2018 Feb 8. No abstract available.

24.

Application of radiopaque micro-particle fillers for 3-D imaging of periodontal pocket analogues using cone beam CT.

Elashiry M, Meghil MM, Kalathingal S, Buchanan A, Elrefai R, Looney S, Rajendran M, Ochieng M, Young N, Elawady A, Arce RM, Sandhage KH, Cutler CW.

Dent Mater. 2018 Apr;34(4):619-628. doi: 10.1016/j.dental.2018.01.008. Epub 2018 Feb 1.

PMID:
29395473
25.

Open letter to journal editors on: International consensus radiochemistry nomenclature guidelines.

Coenen HH, Gee AD, Adam M, Antoni G, Cutler CS, Fujibayashi Y, Jeong JM, Mach RH, Mindt TL, Pike VW, Windhorst AD.

J Labelled Comp Radiopharm. 2018 Apr;61(4):402-404. doi: 10.1002/jlcr.3604. No abstract available.

PMID:
29331022
26.

Management of important adverse events associated with inotuzumab ozogamicin: expert panel review.

Kebriaei P, Cutler C, de Lima M, Giralt S, Lee SJ, Marks D, Merchant A, Stock W, van Besien K, Stelljes M.

Bone Marrow Transplant. 2018 Apr;53(4):449-456. doi: 10.1038/s41409-017-0019-y. Epub 2018 Jan 12. No abstract available.

27.

Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results.

Koreth J, Kim HT, Lange PB, Poryanda SJ, Reynolds CG, Rai SC, Armand P, Cutler CS, Ho VT, Glotzbecker B, Yusuf R, Nikiforow S, Chen YB, Dey B, McMasters M, Ritz J, Blazar BR, Soiffer RJ, Antin JH, Alyea EP 3rd.

Haematologica. 2018 Mar;103(3):522-530. doi: 10.3324/haematol.2017.176859. Epub 2018 Jan 11.

28.

Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCT.

Ho VT, Kim HT, Bavli N, Mihm M, Pozdnyakova O, Piesche M, Daley H, Reynolds C, Souders NC, Cutler C, Koreth J, Alyea EP, Antin JH, Ritz J, Dranoff G, Soiffer RJ.

Blood Adv. 2017 Nov 14;1(24):2269-2279. doi: 10.1182/bloodadvances.2017009084. eCollection 2017 Nov 14.

29.

Phase 1 study of the Hedgehog pathway inhibitor sonidegib for steroid-refractory chronic graft-versus-host disease.

DeFilipp Z, Nazarian RM, El-Jawahri A, Li S, Brown J, Del Rio C, Smith M, Valles B, Ballen KK, McAfee SL, Rosenblatt J, Antin JH, Cutler CS, Chen YB.

Blood Adv. 2017 Oct 5;1(22):1919-1922. doi: 10.1182/bloodadvances.2017011239. eCollection 2017 Oct 10.

30.

Development of radiopaque, biocompatible, antimicrobial, micro-particle fillers for micro-CT imaging of simulated periodontal pockets.

Elashiry M, Meghil MM, Kalathingal S, Buchanan A, Rajendran M, Elrefai R, Ochieng M, Elawady A, Arce RM, Sandhage KH, Cutler CW.

Dent Mater. 2018 Apr;34(4):569-578. doi: 10.1016/j.dental.2017.12.002. Epub 2017 Dec 26.

PMID:
29287980
31.

A North American perspective of content and quality of websites in the English language on childhood-onset lupus erythematosus.

Cutler C, Peng T, Stinson J, Tucker L, Boneparth A, Klein Gitelman M, Moorthy LN.

Lupus. 2018 Apr;27(5):762-770. doi: 10.1177/0961203317746246. Epub 2017 Dec 19.

PMID:
29256340
32.

Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma.

Herrera AF, Rodig SJ, Song JY, Kim Y, Griffin GK, Yang D, Nikolaenko L, Mei M, Bedell V, Dal Cin P, Pak C, Alyea EP, Budde LE, Chen R, Chen YB, Chan WC, Cutler CS, Ho VT, Koreth J, Krishnan A, Murata-Collins JL, Nikiforow S, Palmer J, Pihan GA, Pillai R, Popplewell L, Rosen ST, Siddiqi T, Sohani AR, Zain J, Kwak LW, Weisenburger DD, Weinstock DM, Soiffer RJ, Antin JH, Forman SJ, Nademanee AP, Armand P.

Biol Blood Marrow Transplant. 2018 Mar;24(3):514-520. doi: 10.1016/j.bbmt.2017.11.023. Epub 2017 Nov 28.

PMID:
29196080
33.

Lip repositioning for the treatment of excess gingival display: A systematic review.

Tawfik OK, El-Nahass HE, Shipman P, Looney SW, Cutler CW, Brunner M.

J Esthet Restor Dent. 2018 Mar;30(2):101-112. doi: 10.1111/jerd.12352. Epub 2017 Nov 27. Review.

PMID:
29193632
34.

Transplantation for therapy-related, TP53-mutated myelodysplastic syndrome - not because we can, but because we should.

Cutler C.

Haematologica. 2017 Dec;102(12):1970-1971. doi: 10.3324/haematol.2017.181180. No abstract available.

35.

Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease.

Wang KS, Kim HT, Nikiforow S, Heubeck AT, Ho VT, Koreth J, Alyea EP, Armand P, Blazar BR, Soiffer RJ, Antin JH, Cutler CS, Ritz J.

Blood. 2017 Dec 28;130(26):2889-2899. doi: 10.1182/blood-2017-08-801001. Epub 2017 Nov 14.

PMID:
29138220
36.

Definition and dynamic control of a continuous chromatography process independent of cell culture titer and impurities.

Chmielowski RA, Mathiasson L, Blom H, Go D, Ehring H, Khan H, Li H, Cutler C, Lacki K, Tugcu N, Roush D.

J Chromatogr A. 2017 Dec 1;1526:58-69. doi: 10.1016/j.chroma.2017.10.030. Epub 2017 Oct 13.

PMID:
29078985
37.

Consensus nomenclature rules for radiopharmaceutical chemistry - Setting the record straight.

Coenen HH, Gee AD, Adam M, Antoni G, Cutler CS, Fujibayashi Y, Jeong JM, Mach RH, Mindt TL, Pike VW, Windhorst AD.

Nucl Med Biol. 2017 Dec;55:v-xi. doi: 10.1016/j.nucmedbio.2017.09.004. Epub 2017 Oct 2. Review.

PMID:
29074076
38.

Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402.

Turcotte LM, DeFor TE, Newell LF, Cutler CS, Verneris MR, Wu J, Howard A, MacMillan ML, Antin JH, Vercellotti GM, Slungaard A, Blazar BR, Weisdorf DJ, Panoskaltsis-Mortari A, Holtan SG.

Bone Marrow Transplant. 2018 Jan;53(1):64-68. doi: 10.1038/bmt.2017.236. Epub 2017 Oct 23.

39.

Concurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells.

Geyer MB, Manjunath SH, Evans AG, Park JH, Davila ML, Cutler CS, Wang X, Wang Y, Senechal B, Rivière I, Sadelain M, Liesveld JL, Brentjens RJ.

Leuk Lymphoma. 2018 Jul;59(7):1717-1721. doi: 10.1080/10428194.2017.1390237. Epub 2017 Oct 18. No abstract available.

PMID:
29043880
40.

Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes.

Hamilton BK, Rybicki L, Arai S, Arora M, Cutler CS, Flowers MED, Jagasia M, Martin PJ, Palmer J, Pidala J, Majhail NS, Lee SJ, Khera N.

Biol Blood Marrow Transplant. 2018 Feb;24(2):393-399. doi: 10.1016/j.bbmt.2017.10.009. Epub 2017 Oct 12.

PMID:
29032275
41.

More α Than β for Prostate Cancer?

Fendler WP, Cutler C.

J Nucl Med. 2017 Nov;58(11):1709-1710. doi: 10.2967/jnumed.117.198333. Epub 2017 Sep 21. No abstract available.

PMID:
28935836
42.

Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.

Miklos D, Cutler CS, Arora M, Waller EK, Jagasia M, Pusic I, Flowers ME, Logan AC, Nakamura R, Blazar BR, Li Y, Chang S, Lal I, Dubovsky J, James DF, Styles L, Jaglowski S.

Blood. 2017 Nov 23;130(21):2243-2250. doi: 10.1182/blood-2017-07-793786. Epub 2017 Sep 18.

PMID:
28924018
43.

Radiometric evaluation of diglycolamide resins for the chromatographic separation of actinium from fission product lanthanides.

Radchenko V, Mastren T, Meyer CAL, Ivanov AS, Bryantsev VS, Copping R, Denton D, Engle JW, Griswold JR, Murphy K, Wilson JJ, Owens A, Wyant L, Birnbaum ER, Fitzsimmons J, Medvedev D, Cutler CS, Mausner LF, Nortier MF, John KD, Mirzadeh S, Fassbender ME.

Talanta. 2017 Dec 1;175:318-324. doi: 10.1016/j.talanta.2017.07.057. Epub 2017 Jul 20.

PMID:
28841997
44.

Long-term sustainable dendritic cell-specific depletion murine model for periodontitis research.

Finger Stadler A, Patel M, Pacholczyk R, Cutler CW, Arce RM.

J Immunol Methods. 2017 Oct;449:7-14. doi: 10.1016/j.jim.2017.06.007. Epub 2017 Jun 21.

PMID:
28645528
45.

An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.

Forcade E, Paz K, Flynn R, Griesenauer B, Amet T, Li W, Liu L, Bakoyannis G, Jiang D, Chu HW, Lobera M, Yang J, Wilkes DS, Du J, Gartlan K, Hill GR, MacDonald KP, Espada EL, Blanco P, Serody JS, Koreth J, Cutler CS, Antin JH, Soiffer RJ, Ritz J, Paczesny S, Blazar BR.

JCI Insight. 2017 Jun 15;2(12). pii: 92111. doi: 10.1172/jci.insight.92111. [Epub ahead of print]

46.

Low EGF in myeloablative allotransplantation: association with severe acute GvHD in BMT CTN 0402.

Holtan SG, Newell LF, Cutler C, Verneris MR, DeFor TE, Wu J, Howard A, MacMillan ML, Antin JH, Blazar BR, Weisdorf DJ, Panoskaltsis-Mortari A.

Bone Marrow Transplant. 2017 Sep;52(9):1300-1303. doi: 10.1038/bmt.2017.89. Epub 2017 Jun 5.

PMID:
28581470
47.

A multicenter, retrospective, case-cohort study of the epidemiology and risk factors for Clostridium difficile infection among cord blood transplant recipients.

Alonso CD, Braun DA, Patel I, Akbari M, Oh DJ, Jun T, McMasters M, Hammond SP, Glotzbecker B, Cutler C, Leffler DA, Ballen KK, Kelly CP.

Transpl Infect Dis. 2017 Aug;19(4). doi: 10.1111/tid.12728. Epub 2017 Jul 12.

PMID:
28544102
48.

An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease.

Martin PJ, Storer BE, Inamoto Y, Flowers MED, Carpenter PA, Pidala J, Palmer J, Arora M, Jagasia M, Arai S, Cutler CS, Lee SJ.

Blood. 2017 Jul 20;130(3):360-367. doi: 10.1182/blood-2017-03-775767. Epub 2017 May 11.

49.

Phase 1 multicenter trial of brentuximab vedotin for steroid-refractory acute graft-versus-host disease.

Chen YB, Perales MA, Li S, Kempner M, Reynolds C, Brown J, Efebera YA, Devine SM, El-Jawahri A, McAfee SL, Spitzer TR, Soiffer RJ, Ritz J, Cutler C.

Blood. 2017 Jun 15;129(24):3256-3261. doi: 10.1182/blood-2017-03-772210. Epub 2017 May 4.

50.

Mangiferin functionalized radioactive gold nanoparticles (MGF-198AuNPs) in prostate tumor therapy: green nanotechnology for production, in vivo tumor retention and evaluation of therapeutic efficacy.

Al-Yasiri AY, Khoobchandani M, Cutler CS, Watkinson L, Carmack T, Smith CJ, Kuchuk M, Loyalka SK, Lugão AB, Katti KV.

Dalton Trans. 2017 Oct 31;46(42):14561-14571. doi: 10.1039/c7dt00383h.

PMID:
28440368

Supplemental Content

Loading ...
Support Center